X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-12 | MREO | Scots-Knight Denise | CEO | S - Sale | $4.30 | -88,657 | 808,921 | -10% | -$381,423 | |||||
| M | 2024-09-12 | MREO | Lewicki John A. | Chief Scientific Officer | S - Sale | $4.30 | -16,149 | 92,826 | -15% | -$69,477 | |||||
| M | 2024-09-12 | MREO | Sermon Charles | GC | S - Sale | $4.30 | -30,926 | 219,061 | -12% | -$133,051 | |||||
| M | 2024-09-12 | MREO | Fox Christine Ann | CFO | S - Sale | $4.30 | -28,286 | 89,285 | -24% | -$121,693 | |||||
| M | 2024-09-12 | MREO | Hughes-Wilson Alexandra | See Remarks | S - Sale | $4.30 | -148,110 | 50,475 | -75% | -$637,203 | |||||
| D | 2024-08-22 | MREO | Pakianathan Deepika | Dir | S - Sale+OE | $4.43 | -105,244 | 0 | -100% | -$466,210 | |||||
| M | 2024-06-25 | MREO | Sermon Charles | GC | S - Sale | $3.49 | -46,389 | 184,387 | -20% | -$161,678 | |||||
| M | 2024-06-25 | MREO | Lewicki John A. | Chief Scientific Officer | S - Sale | $3.49 | -24,224 | 62,975 | -28% | -$84,427 | |||||
| M | 2024-06-25 | MREO | Fox Christine Ann | CFO | S - Sale | $3.49 | -42,429 | 57,571 | -42% | -$147,876 | |||||
| M | 2024-06-25 | MREO | Scots-Knight Denise | CEO | S - Sale | $3.49 | -132,985 | 709,518 | -16% | -$463,487 | |||||
| M | 2024-06-25 | MREO | Hughes-Wilson Alexandra | See Remarks | S - Sale | $3.49 | -33,102 | 34,548 | -49% | -$115,369 | |||||
| D | 2024-05-22 | MREO | Hughes-Wilson Alexandra | See Remarks | S - Sale+OE | $2.97 | -100,432 | 7,650 | -93% | -$297,788 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |